Sandoz Settlement Sets Date For US Denosumab Entry

Deal With Amgen Ends Litigation, Allowing Prolia/Xgeva Biosimilars To Launch Next Year

 
• By David Wallace
  
May 2025 calendar
Sandoz will be able to launch in May 2025 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business